期刊文献+

重组人神经肽Y受体Y5融合蛋白的表达、纯化及其生物信息学分析研究 被引量:1

Study on expression,purification and bioinformatic analysis of human neuropeptideY Y5 receptor
下载PDF
导出
摘要 目的在大肠杆菌中表达人神经肽YY5受体,并对之进行纯化、鉴定及生物信息学分析。方法取已构建好且经测序确认无误的重组质粒pET28a-Y5转化大肠杆菌BL21(DE3),IPTG诱导表达融合蛋白,并经SDS-PAGE检测和Western印迹鉴定,表达产物包涵体经Ni2+-NTA亲和层析纯化。然后利用相关在线软件进行生物信息学分析Y5受体蛋白。结果经IPTG诱导含有pET28a-Y5重组质粒的DE3菌,表达出重组人Y5融合蛋白。重组蛋白经Ni2+-NTA亲和层析进行纯化后,得到了较高纯度的融合蛋白。经相关在线软件分析后获得了Y5受体的相关生物学特性。结论重组质粒pET28a-Y5在大肠杆菌DE3中成功表达,亲和层析纯化后获得较高纯度融合蛋白,并对Y5受体蛋白的生物学特征进行了预测,为进一步研究其生物学功能及其抗体的研制奠定了基础。 Objective To express human Y5 receptor protein in E.coli,purify and identify it,and conduct bioinformatic analysis of Y5 receptor.Methods The recombinant plasmid pET28a-Y5 which had been well constructed and sequentially confirmed was transplanted into E.coli BL21(DE3) and induced by IPTG to express fusion proteins.SDS-PAGE and Western blot were used to test and identify the expressed fusion proteins.The inclusion body of the expressed product was purified by Ni2+-NTA affinity chromatography.Then bioinformatic analysis of the Y5 receptor protein was conducted with the help of related online software.Results After being induced by IPTG,the DE3 with recombinant plasmid pET28a-Y5 expressed recombinant human Y5 receptor protein.Highly purified Y5 receptor fusion protein was obtained by Ni^2+-NTA affinity chromatography.Related biological characteristics of Y5 receptor were obtained after the online software analysis.Conclusions The recombinant plasmid pET28a-Y5 can be successfully expressed in DE3.Highly purified proteins can be obtained by Ni2+-NTA affinity chromatography.Y5 receptor's biological characteristics are predicted,which lays foundation for further studies of Y5 receptor's biological function and antibody development.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第20期2609-2613,共5页 Chinese Journal of Gerontology
关键词 人神经肽YY5受体 融合蛋白 包涵体 纯化 生物信息学 NeuropeptideY Y5 receptor Fusion protein Inclusion body Purification Bioinformatics
  • 相关文献

参考文献10

  • 1Ishihara A, Kanatani A, Mashiko S,et al. A neuropeptide Y Y5 antagonist selectively ameliorates bodyweight gain and ass ociated parameters in diet-induced obese mice[J]. PN AS ,2006 ; 103 (18) :7 154-8.
  • 2Pittner RA, Moore CX, Bhavsar SP, et al. Effects of PYY [ 3-36 ] in rodentmodels of diabetes and obesity [ J]. Obes Relat Metab Disord, 2004 ;28 : 963 -71.
  • 3Tang-Christensen M, Kristensen P, Stidsen CE, et al. Centreladministration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y[J]. J Endocrinol, 1998 ; 159:307-12.
  • 4Gerald C ,Walker MW, Criscione L, et al. A receptor subtype involved in neuropeptide Y induced foedintake[J]. Nature, 1996 ;382 : 168-71.
  • 5Schaflhauser AO, Stricker-Krongrad A, Brunner L, et al. Inhibition of food intake by neuropeptideY Y5 receptor antisense ohgodeoxynucleotides [ J]. Diabetes, 1997 ;46 ( 11 ) : 1792 - 1798.
  • 6Sato N, Takahasbl T, Shibata T, et al. Design and synthesis of tbe potent, orally available, brain penetrable arylpyrazole class of neuropeptide Y5 receptor antagonists[ J]. J Med Chem,2003 ;46:666-9.
  • 7Wyss P, Stricker-Krongrad A, Brunner L, et al. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1 ,but not Y2 or Y4 subtypes[J]. Regul Pept,1998;75:363- 71.
  • 8Mashiko S, Ishihara A, Iwaasa H,et al. Characterization of Neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice:chronic intracerebroventricular infusion of D-Trp34NPY [ J]. Endocrinology, 2003 ; 144 : 1793- 801.
  • 9Ishihara A, Kanatani A, Mashiko S, et al. A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice[J]. PNAS,2006 ;103 :7154-8.
  • 10丁克祥,董萍,郑永晨,杨永鹏,朱晓亮,韩晋云,单志新,丁宇,丁振华.与人体肥胖相关的神经肽Y受体Y5基因的克隆及序列分析[J].国际护理学杂志,2009,28(5):713-716. 被引量:2

二级参考文献8

  • 1MacNeil, Douglas J. NPY Y1 and Y5 Receptor selective antagonists as anti-obesity drugs [J] Medicinal Chemistry, 2007, 7:1721-1733.
  • 2Gerald C, Walker MW, Criscionc L, ct al. A receptor subtype involved in neuropeptide Y - induced food intake [J] . Nature, 1996; 382: 168 -171.
  • 3Tang - Christensen M, Kristensen P, Stidsen CE, et al. Central administration of Y5receptor antisensedcoreasess spontaneous food intake and attenuatesfeeding in response to exogenous neuropeptide Y [J] . J Endocrinol, 1998; 159:307-312.
  • 4Schaflhauser AO, Stricker - Krongrad A, Brunner L, et al. Inhibition of foodintake by neuropeptideY Y5 receptor antisense oligodeoxynucleotides [J] . Ddiabetes, 1997, 46 (11): 1792-1798.
  • 5Sato N, Takahashi T, Shibata T, et al. Design and synthesis of the potent, orally available, braipenetrable arylpyrasole class of neuropeptide Y5 receptor antagonists [J] . J Med Chem, 2003, 46:666 -669.
  • 6Wyss P, Stricker - Krongrad A, Brunner L, et al. The pharlnacology of neuropeptideY (NpY) receptor mediated feedingin rats characterizes betterY5 thanY1, but notY2 or Y4 subtypes [J] . Regul PePt, 1998, 75: 363-371.
  • 7Mashiko S, Ishihara A, Iwaasa H, et aL Characterization of neuropeptideY (NPY) Y5 receptor- mediated obesity in mice: chronic intracerebroventricula rlnfusionof of D - Trp34NPY [J] . Endocrinology, 2003, 144: 1793 - 1801.
  • 8Ishihara A, Kanatani A, Mashiko S, et al. A neuropeptide Y Y5 angagonist selectively ameliorates body weight gain and assoeiatde parameters in diet - induced obese mice[ J]. PNAS,2006,103:7154 -7158.

共引文献1

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部